contact@polemicrotechniques.fr
+33 (0)3 81 40 47 55
Devenir membre Inscription newsletter
CanCell Therapeutics

8 rue du Dr Jean François Xavier Girod
25020 BESANCON

Phone +33 6 50 52 31 53

President
Dr Christophe FERRAND
christophe.ferrand@cancell-therapeutics.com

Executive Director
Dr Marina DESCHAMPS
marina.deschamps@cancell-therapeutics.com


CanCell Therapeutics

Activity

CanCell Therapeutics aims to develop advanced therapy medicinal products (ATMP) in oncology, with a first target in leukemia. The immune system of patients reprogrammed and armed, makes it possible to specifically eliminate the tumor, without affecting healthy cells and tissues.


Technologies

Immunotherapy, cell and gene therapy

Final markets

Main :

  • Medical

INFORMATION

Code NAF : 72.19Z

SIRET : 88271775400015

Effective : 4

Capital : 100000 €

Language : English

Discover the members of the Pole

Chargement de l'annuaire en cours...